Background: Ferdinand von Arlt (1812-1887) was one of the greatest ophthalmologists of the 19th century. From 1856 to 1883 he was the head of the First University Eye Clinic in Vienna. The aim of this paper is to show the places where he lived during his working life in Vienna, because it has not been written about so far.
Methods: The article is based on an analysis of the data from Viennese address books of that time, the archives of the University of Vienna, medico-historical books, scientific articles, and internet sources.
Results: During his life in Vienna, Ferdinand von Arlt changed his residential address four times. He lived at Glacis, in Wickenburggasse, Mölkerbastei, and Bellariastrasse. He also had a country house not far from Vienna in Pötzleinsdorf. The paper describes in detail the places in Vienna where he lived and the eye clinic at which he worked. A brief biographical review of von Arlt and his family is also given.
Conclusion: Ferdinand von Arlt was an important representative of the Vienna School of Ophthalmology. The places where he stayed in Vienna were close to the eye clinic. The buildings in which he lived were in representative areas in the city of Vienna. Ultimately he had a large modern apartment, as his family grew over time and with him lived his wife, brother, son, and daughter with their families. This work is a contribution to his rich biography and a wish that the places where he lived Vienna not be forgotten.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10354-021-00843-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after stroke.
Mol Psychiatry
October 2024
Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.
Article Synopsis
- Patients who have suffered a stroke are at higher risk for developing post-stroke dementia, and the presence of serum anti-NMDA receptor autoantibodies (NMDAR1-abs) may negatively impact cognitive outcomes, particularly memory.
- In a study using the DEMDAS cohort, researchers found that 10.2% of stroke patients were seropositive for NMDAR1-abs, but this did not correlate with overall cognitive decline.
- However, those with NMDAR1-abs did show significantly worse performance in memory tasks and were more likely to experience memory impairment one year post-stroke, indicating a specific link between these autoantibodies and memory dysfunction.
Towards Establishing Best Practice in the Analysis of Hydrogen and Deuterium by Atom Probe Tomography.
Microsc Microanal
September 2024
Institute of Materials Engineering, University of Kassel, Moenchebergstr.3, Kassel 34125, Germany.
Article Synopsis
- * Accurate hydrogen mapping and analysis at the microstructural level are essential for understanding how hydrogen causes material embrittlement and impacts future fusion power plants.
- * A workshop at the Max-Planck Institute aimed to establish best practices for using atom probe tomography (APT) to improve the accuracy and reporting of hydrogen analysis in materials.
170th anniversary of Graefe's Archive for Clinical and Experimental Ophthalmology.
Graefes Arch Clin Exp Ophthalmol
October 2024
Eye Hospital, Research Area "History of Ophthalmology", Eberhard-Karls-University, Tübingen, Germany.
The year 2024 marks the 170th anniversary of the journal Graefe's Archive for Clinical and Experimental Ophthalmology. The journal is the first printed journal specializing in ophthalmology, founded by Albrecht von Graefe (1828-1870) in 1854. The reason behind creating the journal was to publish useful clinical information and develop discussion and debate among ophthalmologists and vision scientists.
View Article and Find Full Text PDFUtilization of MANAGE-PD Tool in a Real-World Setting in Germany: A Cross-Sectional Study.
Brain Sci
June 2024
Parkinson-Klinik Ortenau, 77709 Wolfach, Germany.
Article Synopsis
- MANAGE-PD is a web-based tool designed to help doctors identify Parkinson's disease patients whose symptoms aren't well managed by oral medications, with a modified version available in Germany called Parkinson Check.
- A study conducted in Germany in 2022 assessed the real-world utility of both tools using patient and physician ratings of disease control, involving 278 patients from 19 different sites.
- The results showed that 57.6% of patients received the same disease control assessment from both physicians and MANAGE-PD, with higher agreement in specialist clinics compared to neurologist practices, and the Parkinson Check demonstrated strong concordance (>80%) between physician and patient responses.
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their Physicians.
Inflamm Bowel Dis
June 2024
Evangelisches Krankenhaus Kalk, University of Cologne, Cologne, Germany.
Background: The patient perspective is essential for assessing disease severity, but it is not always adequately considered. We describe how a comprehensive clinical disease severity index (DSI) for inflammatory bowel disease (IBD) correlates with patient global self-assessment (PGSA).
Methods: In an individually linked parallel online survey, physicians provided the DSI, and patients provided self-assessed severity using a global question and visual analog scale (0-100) (PGSA).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!